PT84219B - Processo para a preparacao de uma composicao antiviral contendo um nucleosido de purina antiviral e um nucleosido de transporte inibidor - Google Patents

Processo para a preparacao de uma composicao antiviral contendo um nucleosido de purina antiviral e um nucleosido de transporte inibidor

Info

Publication number
PT84219B
PT84219B PT84219A PT8421987A PT84219B PT 84219 B PT84219 B PT 84219B PT 84219 A PT84219 A PT 84219A PT 8421987 A PT8421987 A PT 8421987A PT 84219 B PT84219 B PT 84219B
Authority
PT
Portugal
Prior art keywords
virulent
inhibitory
preparation
composition containing
nucleoside
Prior art date
Application number
PT84219A
Other languages
English (en)
Other versions
PT84219A (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of PT84219A publication Critical patent/PT84219A/pt
Publication of PT84219B publication Critical patent/PT84219B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
PT84219A 1986-01-30 1987-01-29 Processo para a preparacao de uma composicao antiviral contendo um nucleosido de purina antiviral e um nucleosido de transporte inibidor PT84219B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868602346A GB8602346D0 (en) 1986-01-30 1986-01-30 Antiviral combinations

Publications (2)

Publication Number Publication Date
PT84219A PT84219A (en) 1987-02-01
PT84219B true PT84219B (pt) 1989-07-31

Family

ID=10592262

Family Applications (1)

Application Number Title Priority Date Filing Date
PT84219A PT84219B (pt) 1986-01-30 1987-01-29 Processo para a preparacao de uma composicao antiviral contendo um nucleosido de purina antiviral e um nucleosido de transporte inibidor

Country Status (20)

Country Link
US (1) US4897394A (pt)
EP (1) EP0235931B1 (pt)
JP (1) JPS62195337A (pt)
KR (1) KR870006900A (pt)
AT (1) ATE54414T1 (pt)
AU (1) AU590817B2 (pt)
CA (1) CA1283361C (pt)
DD (1) DD261095A5 (pt)
DE (1) DE3763597D1 (pt)
DK (1) DK46787A (pt)
ES (1) ES2031883T3 (pt)
FI (1) FI870377A (pt)
GB (1) GB8602346D0 (pt)
GR (1) GR3000638T3 (pt)
HU (1) HU198394B (pt)
IL (1) IL81422A0 (pt)
MC (1) MC1791A1 (pt)
PL (1) PL263871A1 (pt)
PT (1) PT84219B (pt)
ZA (1) ZA87667B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800081A (en) * 1984-04-18 1989-01-24 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4782065A (en) * 1984-04-18 1988-11-01 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4849412A (en) * 1986-06-05 1989-07-18 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US5879700A (en) * 1991-10-15 1999-03-09 Hostetler; Karl Y. Nucleoside analogue phosphates for topical use
US5580571A (en) * 1991-10-15 1996-12-03 Hostetler; Karl Y. Nucleoside analogues
DE69430569T2 (de) * 1993-02-19 2002-10-31 Southern Research Institute, Birmingham Carbocyclischen deoxyguanosinanaloga zur behandlung von viralen infektionen
WO1994023723A1 (en) * 1993-04-15 1994-10-27 New York University Adenosine receptor agonists for the promotion of wound healing
US5654286A (en) * 1993-05-12 1997-08-05 Hostetler; Karl Y. Nucleotides for topical treatment of psoriasis, and methods for using same
US6015573A (en) * 1993-05-12 2000-01-18 Hostetler; Karl Y. Nucleoside phosphate therapy for viral infection
CA2162574A1 (en) * 1993-05-12 1994-11-24 Karl Y. Hostetler Acyclovir derivatives for topical use
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US5677308A (en) * 1996-12-19 1997-10-14 Lerner; A. Martin Method for alleviating spasmodic torticollis
US5872123A (en) * 1997-02-18 1999-02-16 Lerner; A. Martin Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US6399622B1 (en) 1997-02-18 2002-06-04 A. Martin Lerner Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US6537997B1 (en) 1997-02-18 2003-03-25 A. Martin Lerner Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
PL371945A1 (en) * 2001-10-16 2005-07-11 Avanir Pharmacueticals Viral inhibition by n-docosanol
US20130172536A1 (en) * 2011-08-16 2013-07-04 Shenzhen Weiguang Biological Products Co.,Ltd. Intravenous Cytomegalovirus Human Immune Globulin and Manufacturing Method Thereof
US20140100238A1 (en) 2012-10-04 2014-04-10 Ohio State University Method of diagnosing and treating epstein barr virus-based myalgic encephalomyelitis chronic fatigue syndrome patients
CN105079404A (zh) * 2015-09-07 2015-11-25 夏云强 一种治疗多重耐药菌所致感染性创面的中药外洗剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
PL143208B1 (en) * 1982-10-14 1988-01-30 Wellcome Found Method of obtaining novel 2-amino-9-/2-hydroxyetoxymethyl/purine
GB8320308D0 (en) * 1983-07-28 1983-09-01 Wellcome Found Antiviral combinations
DE3689976T2 (de) * 1985-05-15 1995-03-16 Wellcome Found Therapeutische Nucleoside und deren Herstellung.
DE3627024A1 (de) * 1985-09-24 1987-04-02 Hoechst Ag In 6- und 9-stellung substituierte 2-aminopurine, ihre verwendung, diese purine enthaltende arzneimittel und verfahren zur herstellung der purine
MY101126A (en) * 1985-12-13 1991-07-31 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
CA1283361C (en) 1991-04-23
DK46787D0 (da) 1987-01-29
AU590817B2 (en) 1989-11-16
PL263871A1 (en) 1988-05-12
GR3000638T3 (en) 1991-09-27
AU6813587A (en) 1987-08-06
DK46787A (da) 1987-07-31
HU198394B (en) 1989-10-30
ATE54414T1 (de) 1990-07-15
ZA87667B (en) 1988-09-28
JPS62195337A (ja) 1987-08-28
GB8602346D0 (en) 1986-03-05
DD261095A5 (de) 1988-10-19
DE3763597D1 (de) 1990-08-16
EP0235931A1 (en) 1987-09-09
FI870377A (fi) 1987-07-31
IL81422A0 (en) 1987-08-31
HUT42941A (en) 1987-09-28
MC1791A1 (fr) 1987-10-22
ES2031883T3 (es) 1993-01-01
KR870006900A (ko) 1987-08-13
US4897394A (en) 1990-01-30
PT84219A (en) 1987-02-01
EP0235931B1 (en) 1990-07-11
FI870377A0 (fi) 1987-01-29

Similar Documents

Publication Publication Date Title
PT84219B (pt) Processo para a preparacao de uma composicao antiviral contendo um nucleosido de purina antiviral e um nucleosido de transporte inibidor
EP0135713A3 (en) Antiviral combinations
IL74535A0 (en) Antiviral pharmaceutical compositions containing lidocaine,method for preparation thereof and method of treating viral infections thereby
PT1411954E (pt) Nucleosídeos modificados para o tratamento de infecções virais e proliferação celular anormal
MY121839A (en) Antiviral purine derivatives
CY2058B1 (en) Antiviral pyrimidine and purine compounds process for their preparation and pharmaceutical compositions containing them
DE3854297D1 (de) Nucleoside und nucleotide mit antiviraler, antitumoraler, antimetastatischer sowie immunstimulierender wirkung.
PT90972A (pt) Processo para a preparacao de inibidores de ribonucleotido-redutase, nomeadamente, de tiocarbono-hidrazonas e/ou hidrazinas substituidas e seus derivados e de composicoes farmaceuticas que os contem em associacao com outros compostos antivirais
HU9402582D0 (en) Antiviral nucleoside analoques
EP0334361A3 (en) Novel acetylenic, cyano and allenic aristeromycin/adenosine derivatives
ATE376445T1 (de) Synergistische hemmung von viralreplikation durch langkettigen kohlenwasserstoffe und nucleosid- analoge
PT88948A (pt) Processo para a preparacao de derivados de 3'-fluoro-2',3'-didesoxi-nucleosidos e de composicoes farmaceuticas que os contem
MX9303709A (es) Nucleosidos de purina substituidos e intermediarios de los mismos, que tienen actividad anti-viral y anti-cancerigena y composicion farmaceutica que los contiene.
KR900009083A (ko) 2', 3'-디데옥시푸린 뉴클레오사이드/푸린 뉴클레오 사이드 포스포릴라제 억제제 배합 치료법 및 조성물
ATE71840T1 (de) Virushemmende nukleosidmischung.
DE69813203D1 (de) Verbesserte Primer zur AFLP Amplifizierung
ATE72122T1 (de) Antivirale mischungen.
De Clercq Antiviral nucleoside analogs.
Ohrui et al. Synthesis of conceptually new, potentially anti-viral, low-toxity, acid-and enzyme-stable furanoid and pyranoid nucleosides
Mathé et al. Synthesis and Antiviral Evaluation of 3′-Deoxy-β-L-erythro-pentofuranosyl Nucleosides of the Five Naturally Occurring Nucleic Acid Bases
Kitano et al. Synthesis of 4′-ethynyl-purine nucleosides possessing anti-HIV activity
ES2357811T3 (es) Nucleósidos modificados para el tratamiento de infecciones virales y proliferación celular anormal.
KR890001560A (ko) 항바이어러스 조성물
FR2621816B1 (fr) Application antivirale des ologonucleotides
KR920019362A (ko) 디데옥시 아데노신 및 아데노신 데아미나제 억제물질을 포함하는, 항-hiv활성을 지닌 치료학적 조성물